We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3690:HKEXMeituan Class B Analysis

Data as of 2026-03-10 - not real-time

HK$78.50

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: Meituan is trading at HK$78.5, comfortably below its 20‑day SMA (HK$81.9), 50‑day SMA (HK$92.7) and 200‑day SMA (HK$108.5), signalling a bearish price trend. The 14‑day RSI of 36.4 hints at oversold conditions, while the MACD histogram has turned positive (+0.19) and the MACD line sits above the signal line, offering a tentative bullish signal. Immediate support sits around HK$73.6 with resistance near HK$94.5, framing the short‑term range.
Fundamental outlook: Revenue growth is flat at 2% and margins are deteriorating (operating margin –20%, profit margin –0.55%), with negative ROE and ROA. The trailing PE of 14.8 appears attractive, but the forward PE spikes to 37.5 as earnings are projected to halve, and the DCF‑derived fair value of HK$24.1 suggests a substantial valuation gap. The company carries a debt‑to‑equity ratio of 30.6% and pays no dividend despite holding HK$141.3B in cash. The recent acquisition of Dingdong’s fresh‑grocery platform adds a strategic growth catalyst, and analysts maintain a “buy” consensus with a median target of HK$123.7, implying upside of roughly 57%.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below key moving averages
  • Positive MACD histogram
  • Support above current price

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst price targets indicating >50% upside
  • Strategic acquisition of Dingdong grocery platform
  • Improving cash position despite margin pressure

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Potential for margin recovery through new initiatives
  • Strong market position in Chinese local commerce
  • Long‑term upside relative to DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth2.00%
Profit Margin-0.55%
P/E Ratio14.8
ROE-1.21%
ROA-0.91%
Debt/Equity30.63
P/B Ratio2.4
Op. Cash FlowHK$9.6B
Free Cash FlowHK$3.8B

Technical Analysis

TrendBearish
RSI36.4
SupportHK$73.60
ResistanceHK$94.50
MA 20HK$81.88
MA 50HK$92.74
MA 200HK$108.52
MACDBullish
VolumeStable
Fear & Greed Index75.89

Valuation

Fair ValueHK$24.13
Target PriceHK$117.88
Upside/Downside50.16%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.02
Volatility36.43%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.